Friday, September 4, 2026

Drug Price Reform Plan Prompts Emergency Meeting by South Korean Pharma Group

The Korea Pharmaceutical and Bio-Pharma Association plans strategies to address the new drug price reform and improve the industry.

Naver to remove Chinese components from AI models, fully adopt in-house vision encoder

Naver will replace its controversial Chinese vision encoder with a self-developed one to enhance its AI models for Korean language and culture.

North Korea Human Rights Committee Disbanded: What This Means for 2026

The Ministry of Unification has dissolved the North Korean Human Rights Promotion Committee, redirecting funds to unification initiatives.

Tag: long-acting injectables

IVL3021 vs Wegovy: The Future of Long-Acting Obesity Treatments Revealed

Inventage Lab's IVL3021 shows promising long-term obesity treatment results, outperforming competitors with effective weight maintenance strategies.

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Revolutionary Long-Lasting Injections: How IVL3003 and IVL3004 are Transforming Dementia and Addiction Treatments

Inventage Lab will present promising results from clinical trials of two long-acting injectables at the 2026 AAN meeting in Chicago.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

Long-Acting HIV Treatment Vocabria + Rekambys Offers New Hope with Just Six Injections a Year

Long-acting HIV treatment Vocabria + Rekambys improves adherence and quality of life, reducing daily pill burden to six injections yearly.

Top News

- Our Sponsors Ad -

Follow us